| Literature DB >> 32948240 |
Zihua Li1, Xinbo Wu1, Haichao Zhou1, Shaochen Xu1, Fajiao Xiao1, Hui Huang1, Yunfeng Yang2.
Abstract
BACKGROUND: Extensile lateral approach had been recognized as the gold standard technique for displaced intra-articular calcaneus fractures (DIACFs) while sinus tarsi approach had been increasingly valued by surgeons and comparative clinical outcome was shown in both techniques. Appropriate decisions could be made by the clinicians with the help of cost-utility analysis (CUA) about optimal healthcare for type II/III calcaneus fracture.Entities:
Keywords: Calcaneus fracture; Cost-utility analysis; Extensile lateral approach; Sinus tarsi approach
Mesh:
Year: 2020 PMID: 32948240 PMCID: PMC7501640 DOI: 10.1186/s13018-020-01963-5
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.359
Fig.1a The preoperative lateral image demonstrates collapse of the Bohler’s angle and posterior facet. b Intraoperative gross image of surgery via the extensile lateral approach (ELA). c The postoperative lateral image shows restoration of the Bohler’s angle and posterior facet by plate and screws. d The axial image shows restoration of the width and alignment of calcaneus
Fig. 2a The preoperative lateral image shows fracture line involving the subtalar joint. b Intraoperative gross image of surgery via the sinus tarsi approach (STA). c The postoperative lateral image shows restoration of Bohler’s angle, and fracture line involving subtalar joint was reduced by screws. d The axial image shows the normal alignment of calcaneus
Patient information
| Parameters | ELA ( | STA ( | |
|---|---|---|---|
| Age (years) | 45.40 ± 12.91 | 49.92 ± 14.98 | .095 |
| Gender | .522 | ||
| Male | 51 | 38 | |
| Female | 11 | 9 | |
| Fracture type | .516 | ||
| Sanders II | 36 | 28 | |
| Sanders III | 26 | 19 | |
| Anesthesia | .860 | ||
| Spinal anesthesia | 52 | 40 | |
| General anesthesia | 10 | 7 | |
| The length of hospital stay | 10.9 ± 3.7 | 9.4 ± 3.6 | .060 |
| Follow-up time (month) | 30.5 ± 9.7 | 28.4 ± 13.5 | .150 |
Data are means ± SD and numbers of subjects. Significant difference (P < .05)
ELA Extensile lateral approach, STA Sinus tarsi approach
Clinical outcome
| Parameters | ELA ( | STA ( | |
|---|---|---|---|
| VAS scores | |||
| Preoperative | 6.9 ± 1.1 | 6.6 ± 1.0 | .151 |
| Postoperative 3 days | 4.6 ± 0.9 | 3.0 ± 0.8 | < .001 |
| Postoperative 5 days | 2.3 ± 0.7 | 1.8 ± 0.5 | .002 |
| Postoperative 7 days | 1.6 ± 0.5 | 1.5 ± 0.5 | .693 |
| AOFAS | |||
| Preoperative | 50.0 ± 8.0 | 51.2 ± 7.9 | .413 |
| Postoperative 3 months | 80.3 ± 6.3 | 81.4 ± 5.6 | .325 |
| Final follow-up | 83.7 ± 4.6 | 85.0 ± 4.0 | .113 |
| Bohler’s angle (degrees) | |||
| Preoperation | 13.6 ± 7.3 | 16.0 ± 7.4 | .086 |
| Postoperative 3 months | 30.2 ± 7.6 | 28.2 ± 7.1 | .053 |
| Final follow-up | 29.9 ± 6.6 | 28.4 ± 6.3 | .065 |
| Gissane angle (degrees) | |||
| Pre-operation | 102.8 ± 14.2 | 102.0 ± 12.5 | .920 |
| Postoperative 3 months | 130.0 ± 9.2 | 127.7 ± 8.2 | .255 |
| Final follow-up | 126.0 ± 7.5 | 128.2 ± 7.8 | .139 |
| Preoperative EQ-5D score | 0.63 (0.57–0.68) | 0.59 (0.52–0.68) | .246 |
| Postoperative EQ-5D | 0.92 (0.89–0.95) | 0.93 (0.88–0.95) | .755 |
| Gained QALY | 0.77 (0.73–0.80) | 0.75 (0.69–0.79) | .250 |
EQ-5D EuroQol five-dimensional, VAS Visual Analogue Scale, AOFAS American Orthopaedic Foot and Ankle Society, QALY Quality-adjusted life-year
Health care cost
| Parameters | ELA ( | STA ( | |
|---|---|---|---|
| Laboratory expense | $143.1 ± 42.9 | $160.8 ± 109.5 | .605 |
| Radiography | $78.1 ± 21.8 | $80.8 ± 15.1 | .217 |
| CT | $46.3 ± 21.8 | $44.5 ± 21.7 | .506 |
| Surgery | $396.3 ± 130.5 | $442.9 ± 202.7 | .376 |
| Anesthesia | $146.3 ± 67.5 | $142.0 ± 70.1 | .778 |
| Analgesia | $145.8 ± 85.6 | $102.9 ± 62.7 | .008 |
| Internal fixation materials | $3289.0 ± 543.9 | $2630.6 ± 763.7 | < .001 |
| Antibiotic drugs | $85.0 ± 44.6 | $76.5 ± 54.9 | .104 |
| Total cost | $6481.0 ± 1504.4 | $5838.8 ± 1276.2 | .200 |
Values represent the mean cost per patient in January 2020 US dollars. Significant difference (P < .05)
CT Computed tomography
Cost-effectiveness ratios (CERs)
| Parameters | ELA ( | STA ( | |
|---|---|---|---|
| Cost | $6481.0 ± 1504.4 | $5838.8 ± 1276.2 | .200 |
| Utility (QALY) | 0.77 (0.73–0.80) | 0.75 (0.69–0.79) | .755 |
| CERs | $8766.8 ± 2835.2 | $7914.9 ± 1822.0 | .245 |
QALY Quality-adjusted life-year
Incremental cost-effectiveness ratio (ICER)
| Parameters | Normal | 3% Discount | 5% Discount |
|---|---|---|---|
| ΔCost | 642.20 | 623.51 | 605.36 |
| ΔQALY | 0.02 | 1.942 × 10−2 | 1.94 × 10−2 |
| ICER (Δcost/ΔQALY) | 32,110.00 | 32,106.59 | 31,794.26 |
ICER Incremental cost-effectiveness ratio